Harbour Investments’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6
Closed -$9K 3869
2021
Q1
$9K Buy
+6
New +$14.1K ﹤0.01% 2666

Other funds holding LABU

Harbour Investments's LABU Position: Q2 2021 in Review

Harbour Investments sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2021, closing a stake of 6 shares — an estimated $9K sold.

Harbour Investments first reported a position in LABU in Q1 2021 and held it in 1 quarter. The position peaked at $9K in Q1 2021. 24 funds tracked by Wall St. Rank hold LABU as of Q2 2021.

  • Harbour Investments reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2021 after selling out during the quarter.
  • Harbour Investments sold 6 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2021, an estimated $9K.
  • Harbour Investments first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2021 and held it in 1 quarter.
  • Harbour Investments's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $9K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2021.

Based on Harbour Investments's 13F filing for Q2 2021, filed 16 Aug 2021.